Outlook Therapeutics (OTLK) Assets: 2015-2019
Historic Assets for Outlook Therapeutics (OTLK) over the last 5 years, with Sep 2019 value amounting to $17.1 million.
- Outlook Therapeutics' Assets fell 8.95% to $30.2 million in Q2 2020 from the same period last year, while for Jun 2020 it was $30.2 million, marking a year-over-year decrease of 8.95%. This contributed to the annual value of $17.1 million for FY2019, which is 23.10% down from last year.
- According to the latest figures from FY2019, Outlook Therapeutics' Assets is $17.1 million, which was down 23.10% from $22.3 million recorded in FY2018.
- In the past 5 years, Outlook Therapeutics' Assets registered a high of $35.0 million during FY2015, and its lowest value of $17.1 million during FY2019.
- For the 3-year period, Outlook Therapeutics' Assets averaged around $20.1 million, with its median value being $20.7 million (2017).
- As far as peak fluctuations go, Outlook Therapeutics' Assets declined by 27.43% in 2016, and later rose by 7.47% in 2018.
- Yearly analysis of 5 years shows Outlook Therapeutics' Assets stood at $35.0 million in 2015, then fell by 27.43% to $25.4 million in 2016, then decreased by 18.39% to $20.7 million in 2017, then climbed by 7.47% to $22.3 million in 2018, then declined by 23.10% to $17.1 million in 2019.